The Discounted Cash Flow (DCF) valuation of Taro Pharmaceutical Industries Ltd (TARO) is 42.34 USD. With the latest stock price at 42.97 USD, the upside of Taro Pharmaceutical Industries Ltd based on DCF is -1.5%.
Based on the latest price of 42.97 USD and our DCF valuation, Taro Pharmaceutical Industries Ltd (TARO) is a sell. selling TARO stocks now will result in a potential gain of 1.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.4% | 6.7% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 31.93 - 75.43 | 42.34 |
| Upside | -25.7% - 75.5% | -1.5% |